| Income Statement |
| Total Revenue | 144.63M |
|
| Revenues (USD) | 144.63M |
| Cost of Revenue | 72.18M |
| Gross Profit | 72.45M |
| Operating Expenses | 6.20M |
| Research and Development Expense | 722.00K |
| Selling, General and Administrative Expense | 5.48M |
| Operating Income | 66.26M |
| Interest Expense | 5.72M |
| Income Tax Expense | 22.96M |
| Net Income | 32.69M |
| Net Income Common Stock | 32.69M |
| Net Income Common Stock (USD) | 32.69M |
| Consolidated Income | 36.86M |
| Net Income to Non-Controlling Interests | 4.17M |
| Earnings per Basic Share | 0.13 |
| Earnings per Basic Share (USD) | 0.13 |
| Earnings per Diluted Share | 0.12 |
| Earning Before Interest & Taxes (EBIT) | 61.37M |
| Earning Before Interest & Taxes (USD) | 61.37M |
| Weighted Average Shares | 260.28M |
| Weighted Average Shares Diluted | 269.73M |
| Balance Sheet |
| Cash and Equivalents | 114.94M |
| Cash and Equivalents (USD) | 114.94M |
| Trade and Non-Trade Receivables | 189.00K |
| Current Assets | 238.36M |
| Property, Plant & Equipment Net | 404.71M |
| Total Assets | 651.23M |
| Debt Current | 100.97M |
| Total Debt | 117.40M |
| Current Liabilities | 246.97M |
| Debt Non-Current | 16.43M |
| Total Liabilities | 389.82M |
| Accumulated Retained Earnings (Deficit) | -422.29M |
| Shareholders Equity | 254.43M |
| Shareholders Equity (USD) | 254.43M |
| Assets Non-Current | 412.87M |
| Total Debt (USD) | 117.40M |
| Inventory | 86.74M |
| Liabilities Non-Current | 142.85M |
| Trade and Non-Trade Payables | 90.44M |
| Tax Assets | 23.77M |
| Tax Liabilities | 42.65M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 12.41M |
| Net Cash Flow from Financing | -10.83M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 6.61M |
| Issuance (Purchase) of Equity Shares | 1.26M |
| Issuance (Repayment) of Debt Securities | -113.00K |
| Net Cash Flow from Investing | -35.61M |
| Net Cash Flow from Operations | 46.69M |
| Effect of Exchange Rate Changes on Cash | -175.00K |
| Share Based Compensation | 1.38M |